Arbutus Biopharma Corporation
ABUS • NASDAQ
Arbutus Biopharma Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lindsay Androski, with a market cap of $840.6M.
Market Cap$840.6M
Employees73.0
CEOLindsay Androski
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Arbutus Biopharma Corporation FAQ
Common questions about Arbutus Biopharma Corporation
Arbutus Biopharma Corporation is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $1.5M.
Arbutus Biopharma Corporation has approximately 73 employees.